Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

CHICAGO >> Treating breast cancer patients with AstraZeneca’s experimental pill camizestrant at the first sign of resistance ...

By Julie Steenhuysen CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at ...

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid ...

AstraZeneca CEO Pascal Soriot views the company's stock price — up just 10% year-to-date — as a marker of how he is doing. He ...

Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of ...

The results, presented at the American Society of Clinical Oncology meeting in Chicago, mark the first use of a blood test ...

AstraZeneca Plc’s experimental breast cancer pill delayed disease progression by over six months, according to data from a ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a bispecific antibody newly licensed by Pfizer.

Test tubes are seen in front of a displayed AstraZeneca logo in this illustration taken on May 21 ... The company is also establishing a new supply base in Qingdao, Shandong province. According to Lai ...

P UMA has officially unveiled the new logo for its collab with NBA player Tyrese Haliburton. In a provocative clapback to ...